oleic acid has been researched along with Demyelinating Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amor, S; Bazinet, RP; Hildebrand, KD; Kipp, M; Nyamoya, SD; Trépanier, MO | 1 |
| Cho, BM; Kim, HJ; Kim, YW; Lee, TH; Moon, TY; Park, BR; Pyeun, YS; Suh, KT | 1 |
2 other study(ies) available for oleic acid and Demyelinating Diseases
| Article | Year |
|---|---|
Phosphatidylcholine 36:1 concentration decreases along with demyelination in the cuprizone animal model and in post-mortem multiple sclerosis brain tissue.
Topics: Adult; Aged; Aged, 80 and over; Animals; Brain; Chelating Agents; Corpus Callosum; Cuprizone; Demyelinating Diseases; Female; Humans; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Middle Aged; Multiple Sclerosis; Myelin Sheath; Oleic Acid; Phosphatidylcholines; Postmortem Changes | 2018 |
A model for research on the blood-brain barrier disruption induced by unsaturated fatty acid emulsion.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Edema; Carotid Artery, Internal; Cats; Demyelinating Diseases; Diffusion Magnetic Resonance Imaging; Disease Models, Animal; Emulsions; Gadolinium DTPA; Image Enhancement; Injections, Intra-Arterial; Linoleic Acid; Necrosis; Oleic Acid; Time Factors | 2005 |